Web Results

Mivacurium chloride


Mivacurium chloride is a short-duration non-depolarizing neuromuscular- blocking drug or skeletal muscle relaxant in the category of non-depolarizing ...

Mivacurium - FDA prescribing information, side effects and uses


mivacurium official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.

DrugBank: Mivacurium


Jun 13, 2005 ... Mivacurium is a bisbenzylisoquinolinium based neuromuscular blocker or muscle relaxant. It binds competitively to cholinergic receptors on the ...

Mivacurium | C58H80N2O14+2 - PubChem


Mivacurium is a bisbenzylisoquinolinium based neuromuscular blocker or muscle relaxant. It binds competitively to cholinergic receptors on the motor end- plate ...

Mivacron (Mivacurium Chloride Injection): Side Effects, Interactions ...


Feb 24, 2015 ... Learn about Mivacron (Mivacurium Chloride Injection) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, ...

mivacurium chloride injection : Uses, Side Effects, Interactions ...


Find patient medical information for mivacurium chloride injection on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ...

Mivacurium: Brands, Medical Use, Clinical Data - Druglib


Mivacurium is a short-acting, nondepolarizing skeletal neuromuscular blocking agent which is hydrolyzed by plasma cholinesterase. Mivacurium results in a ...

Mivacron Injection 2 mg/ml - Summary of Product Characteristics ...


Jul 29, 2014 ... Name of the medicinal product. Mivacron<sup>®</sup> Injection 2 mg/ml. 2. Qualitative and quantitative composition. Mivacurium chloride 2.14 mg in each ...

Pharmacokinetics and pharmacodynamics of the three ... - BJA


trans-trans and cis-cis mivacurium in nine healthy patients (creatinine clearance 66œ133 ml minJ1), in seven patients with end-stage renal failure requiring ...

Mivacurium-induced prolonged neuromuscular block - BJA


We report a case of prolonged neuromuscular block after administration of mivacurium 0.2 mg kg"1 to a. 16-yr-old patient where the duration of block was. 2.5 h.

Find Health Information on Healthline
Find Info About:
Healthline is the leading provider of health information.
More Info

Mivacurium Drug Information, Professional - Drugs.com


Mivacurium Drug Information from Drugs.com. Includes Mivacurium side effects, interactions and indications.

Clinical pharmacology of mivacurium chloride: a review. - NCBI


Mivacurium chloride (Mivacron) is a new benzylisoquinolinium choline-like diester neuromuscular blocking drug with an onset of action at equipotent doses that ...

Mivacurium. A review of its pharmacology and therapeutic potential ...


Mivacurium is a potent nondepolarising neuromuscular blocking agent which is structurally related to the benzylisoquinolinium compound, atracurium.